TL;DR:
- Medanta Hospital in Gurugram employs AI to treat a 62-year-old patient with severe blood clots.
- Penumbra Flash 12 F Catheter, an AI-driven device, used for precise clot removal during endovascular procedures.
- Since July 2023, Medanta has successfully treated 25 cases of pulmonary embolism, reducing blood loss and expediting recovery.
- AI technology allows for clot extraction without invasive surgery, minimizing risks.
- The patient experiences local anesthesia and remains awake during the procedure.
- The PERT program was launched to raise awareness about pulmonary embolism.
- This achievement signifies a remarkable advancement in healthcare, offering faster recovery and improved outcomes.
Main AI News:
In a significant leap towards the advancement of medical technology, Medanta Hospital, situated in Haryana’s Gurugram, has achieved a historic milestone by employing Artificial Intelligence (AI) to treat a 62-year-old patient suffering from both a pulmonary embolism and a deep vein blood clot. This remarkable feat has firmly established Medanta as the pioneer in the country to embrace such cutting-edge AI technology within the realm of healthcare.
The pivotal tool in this groundbreaking endeavor is the Penumbra Flash 12 F Catheter, a state-of-the-art AI-driven device meticulously utilized to eliminate blood clots through endovascular procedures. Since July 2023, Medanta Hospital has effectively managed and successfully treated 25 cases of pulmonary embolism, a debilitating condition that obstructs blood flow to the lung’s artery, often leading to severe complications.
What sets this “ground-breaking technology” apart is its remarkable ability to minimize blood loss during procedures, thereby reducing complications, including anemia, while simultaneously expediting the patient’s road to recovery. Unlike traditional methods that necessitate invasive surgery and carry inherent risks, the use of AI technology now allows for the precise extraction of clots without compromising the patient’s blood volume. Dr. Naresh Trehan, the esteemed cardiologist and Chairman of Medanta Hospital, emphasized this transformative shift, stating, “Instead of opening the chest and the arteries, you can suck out the blood clots. The AI aspect is where you can suck out the clots without sucking out the blood. In the past, we would have to do a major operation, and there would be an element of risk as well.”
One notable case highlighting the efficacy of this approach involved Narendra Singh, a professional pilot, who sought emergency medical attention with symptoms of shortness of breath, sudden leg pain, and swelling. Dr. Tarun Grover, who skillfully performed the procedure using the Penumbra Flash 12 F catheter, recounted the success, stating, “Using the Penumbra Flash 12 F catheter, the blood clots were removed. This approach navigated complex veins and provided immediate relief from pain and swelling. The patient was cleared for discharge within 48 days with follow-up treatment instructions.”
The innovative procedure distinguishes itself from conventional surgical methods by being administered under local anesthesia, allowing the patient to remain awake and witness the intervention firsthand. Dr. Rajiv Parakh, an Endovascular specialist, further emphasized the merits of this approach, stating, “Unlike other procedures that may result in considerable blood loss and longer recovery, Penumbra Lightning minimizes such risks. It ensures quicker rehabilitation, reduces complications and improves overall recovery time.”
Dr. Naresh Trehan added his perspective, stating, “The introduction of this technology signifies a remarkable advancement in aiding individuals afflicted with pulmonary embolism, enabling faster recovery and improved outcomes.” As part of its commitment to raising awareness and improving outcomes for pulmonary embolism patients, Medanta Hospital has also launched a PERT (Pulmonary Embolism Interventions and Response Team) program.
AI helps to remove blood clots with minimal surgical procedure. Source: Living Media Limited
Conclusion:
Medanta Hospital’s groundbreaking use of AI technology to treat severe blood clots signifies a significant leap in healthcare innovation. This transformative approach not only enhances patient outcomes but also paves the way for the integration of cutting-edge technology in the medical field, presenting new opportunities and advancements in the market for AI-driven healthcare solutions.
